Whittier Trust CO Horizon Therapeutics Public LTD CO Transaction History

Whittier Trust CO

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 27, 2023	BUY	$98.98 - $115.74 $1,583 - $1,851	16 New	16 $1,000
Q1 2023 Apr 21, 2023	SELL	$107.32 - $113.5 $16,956 - $17,933	-158 Reduced 16.67%	790 $86,000
Q4 2022 Jan 25, 2023	SELL	$62.39 - $113.8 $1,123 - $2,048	-18 Reduced 1.86%	948 $0
Q3 2022 Oct 21, 2022	SELL	$58.92 - $84.67 $7,011 - $10,075	-119 Reduced 10.97%	966 $60,000
Q2 2022 Jul 28, 2022	BUY	$79.4 - $116.36 $9,448 - $13,846	119 Added 12.32%	1,085 $87,000
Q1 2022 Apr 29, 2022	BUY	$86.42 - $109.81 $1,555 - $1,976	18 Added 1.9%	966 $102,000
Q3 2021 Nov 01, 2021	BUY	$91.91 - $110.37 $87,130 - $104,630	948 New	948 $104,000
Q3 2020 Oct 30, 2020	SELL	$55.23 - $79.93 $2,761 - $3,996	-50 Closed	0 $0
Q1 2020 Apr 27, 2020	BUY	$24.87 - $38.56 $621 - $964	25 Added 100.0%	50 $1,000
Q2 2019 Jul 23, 2019	BUY	$22.81 - $28.48 $570 - $712	25 New	25 $1,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Whittier Trust CO, based on Form 13F filings with the SEC.

Stay updated on Whittier Trust CO with notifications on news.